During the past decade, Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite" are "Beta-Thalassemia" (2 trials), "Beta-thalassemia" (1 trials), "Erythrocyte Transfusion" (1 trials), "Haemoglobinopathies" (1 trials) and "Myelodysplastic Syndromes (MDS)" (1 trials). Many other conditions were trialed in "Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite" in a lesser frequency.

Most popular intervention types in "Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Luspatercept" (3 trials), "Placebo" (2 trials), "ACE-536" (1 trials) and "Best Supportive Care (BSC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".